GlaxoSmithKline PLC's ticker is and the CUSIP is G3910J112. A total of 5 filers reported holding GlaxoSmithKline PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $660,000 | -11.6% | 35,204 | -4.4% | 0.01% | -16.7% |
Q2 2020 | $747,000 | +5.1% | 36,821 | -2.5% | 0.01% | 0.0% |
Q1 2020 | $711,000 | -25.9% | 37,766 | -7.3% | 0.01% | +9.1% |
Q4 2019 | $960,000 | +2.9% | 40,737 | -6.4% | 0.01% | 0.0% |
Q3 2019 | $933,000 | -4.6% | 43,507 | -9.1% | 0.01% | 0.0% |
Q2 2019 | $978,000 | -8.9% | 47,882 | -7.3% | 0.01% | -31.2% |
Q1 2019 | $1,074,000 | -16.7% | 51,667 | -23.8% | 0.02% | -20.0% |
Q4 2018 | $1,290,000 | -4.9% | 67,832 | +0.1% | 0.02% | +11.1% |
Q3 2018 | $1,357,000 | -0.4% | 67,762 | +0.4% | 0.02% | 0.0% |
Q2 2018 | $1,363,000 | -12.0% | 67,522 | -14.7% | 0.02% | -5.3% |
Q1 2018 | $1,548,000 | +107.0% | 79,151 | +89.1% | 0.02% | +111.1% |
Q4 2017 | $748,000 | -55.9% | 41,851 | -50.8% | 0.01% | -55.0% |
Q3 2017 | $1,695,000 | -15.8% | 84,999 | -10.0% | 0.02% | -20.0% |
Q2 2017 | $2,012,000 | +26.3% | 94,441 | +23.3% | 0.02% | +25.0% |
Q1 2017 | $1,593,000 | +8.2% | 76,588 | +0.1% | 0.02% | 0.0% |
Q4 2016 | $1,472,000 | -13.7% | 76,498 | -4.4% | 0.02% | -4.8% |
Q3 2016 | $1,705,000 | -2.2% | 80,042 | -2.0% | 0.02% | 0.0% |
Q2 2016 | $1,744,000 | +6.2% | 81,637 | +0.9% | 0.02% | +5.0% |
Q1 2016 | $1,642,000 | +23.9% | 80,885 | +23.6% | 0.02% | +25.0% |
Q4 2015 | $1,325,000 | -20.6% | 65,465 | -24.9% | 0.02% | -15.8% |
Q3 2015 | $1,669,000 | -11.1% | 87,135 | -3.6% | 0.02% | 0.0% |
Q2 2015 | $1,878,000 | -10.7% | 90,369 | -1.4% | 0.02% | -9.5% |
Q1 2015 | $2,102,000 | +18.0% | 91,609 | +10.3% | 0.02% | -8.7% |
Q4 2014 | $1,782,000 | -22.6% | 83,079 | -17.3% | 0.02% | +4.5% |
Q3 2014 | $2,302,000 | -35.0% | 100,490 | -24.1% | 0.02% | -33.3% |
Q2 2014 | $3,539,000 | -1.8% | 132,350 | -2.6% | 0.03% | -5.7% |
Q1 2014 | $3,604,000 | +0.7% | 135,835 | +1.3% | 0.04% | 0.0% |
Q4 2013 | $3,580,000 | -16.6% | 134,115 | -21.2% | 0.04% | -25.5% |
Q3 2013 | $4,290,000 | -0.3% | 170,105 | -1.2% | 0.05% | -7.8% |
Q2 2013 | $4,301,000 | – | 172,090 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cullen Capital Management, LLC | 498,400 | $11,417,000 | 0.31% |
ArchPoint Investors | 11,370 | $260,000 | 0.22% |
Zions Trust, National Association | 1,170 | $27,000 | 0.04% |
MYCIO WEALTH PARTNERS, LLC | 5,782 | $132,000 | 0.03% |
SCHAFER CULLEN CAPITAL MANAGEMENT INC | 100,490 | $2,302,000 | 0.02% |
AMERIPRISE FINANCIAL INC | 43 | $1,000 | 0.00% |